Literature DB >> 22404820

Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review.

James E Morgan1.   

Abstract

Retinal ganglion cell degeneration has been reported in a range of experimental models of glaucoma. Manifest as pruning of retinal ganglion cell dendrites, it is likely to influence both the function and viability of affected cells. Electrophysiological studies in primate glaucoma have shown that affected cells retain some function and could therefore form a neural substrate for the recovery of visual function in glaucoma. Clinical studies in which the intraocular pressure is reduced have suggested that some improvement in retinal function may be possible in hypotensive eyes. These experimental studies highlight the importance of establishing the extent to which retinal ganglion cell degeneration occurs in human glaucoma. If substantial numbers of degenerating retinal ganglion cells are present in glaucoma, they could present an ideal target for the recovery of vision.
© 2012 The Author. Clinical and Experimental Ophthalmology © 2012 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Mesh:

Year:  2012        PMID: 22404820     DOI: 10.1111/j.1442-9071.2012.02789.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  23 in total

Review 1.  In vivo imaging methods to assess glaucomatous optic neuropathy.

Authors:  Brad Fortune
Journal:  Exp Eye Res       Date:  2015-06-03       Impact factor: 3.467

2.  Subtype-dependent Morphological and Functional Degeneration of Retinal Ganglion Cells in Mouse Models of Experimental Glaucoma.

Authors:  Zhen Puyang; Hui Chen; Xiaorong Liu
Journal:  J Nat Sci       Date:  2015-05-01

Review 3.  Differential gene expression in glaucoma.

Authors:  Tatjana C Jakobs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

4.  The optical detection of retinal ganglion cell damage.

Authors:  J E Morgan; J Tribble; J Fergusson; N White; I Erchova
Journal:  Eye (Lond)       Date:  2017-01-06       Impact factor: 3.775

Review 5.  Axon injury signaling and compartmentalized injury response in glaucoma.

Authors:  Stephanie B Syc-Mazurek; Richard T Libby
Journal:  Prog Retin Eye Res       Date:  2019-07-10       Impact factor: 21.198

6.  Risk factors for microcystic macular oedema in glaucoma.

Authors:  Golnoush Mahmoudinezhad; Diana Salazar; Esteban Morales; Peter Tran; Janet Lee; Jean-Pierre Hubschman; Kouros Nouri-Mahdavi; Joseph Caprioli
Journal:  Br J Ophthalmol       Date:  2021-11-05       Impact factor: 5.908

7.  Can Visual Field Progression be Predicted by Confocal Scanning Laser Ophthalmoscopic Imaging of the Optic Nerve Head in Glaucoma? (An American Ophthalmological Society Thesis).

Authors:  John Danias; Janet Serle
Journal:  Trans Am Ophthalmol Soc       Date:  2015

8.  Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension.

Authors:  Sarah Naguib; Jon R Backstrom; Melanie Gil; David J Calkins; Tonia S Rex
Journal:  Redox Biol       Date:  2021-01-29       Impact factor: 11.799

Review 9.  Ocular perfusion pressure and ocular blood flow in glaucoma.

Authors:  A Popa Cherecheanu; G Garhofer; D Schmidl; R Werkmeister; L Schmetterer
Journal:  Curr Opin Pharmacol       Date:  2012-09-23       Impact factor: 5.547

10.  Retinal ganglion cell dendritic atrophy in DBA/2J glaucoma.

Authors:  Pete A Williams; Gareth R Howell; Jessica M Barbay; Catherine E Braine; Gregory L Sousa; Simon W M John; James E Morgan
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.